Form 8-K IDEAYA Biosciences, Inc. For: Apr 23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St set to snap three-day streak of losses despite Middle East clashes
- Oil rises, as US-Iran strikes risk limiting already impaired supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
IDEAYA Biosciences (IDYA) Announces $150M Proposed Public Offering of Common Stock
April 24, 2023 4:13 PM EDTIDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced that it intends to offer and sell up to $150 million of shares of its common stock in an underwritten public offering. In addition, IDEAYA intends to grant the underwriters a 30-day option to purchase up to $22.5 million of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the... More
Ideaya (IDYA) PT Raised to $30 at Oppenheimer, 'we believe, at this market cap. near-term focus now shifts to the pipeline. Reiterate Outperform'
April 24, 2023 10:39 AM EDTOppenheimer analyst Matthew Biegler raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $30.00 (from $26.00) while maintaining a Outperform rating.
The analyst comments "Monday, IDEAYA held a call to discuss updates from its darovasertib franchise in uveal melanoma. With nearly twice... More
